The role of IRF9 in tumor suppression is mainly implicated in the context of type I Interferon (IFN)-mediated antitumor activities through Janus Kinases/STAT pathway [23], as shown in Supplementary Figure S1. This evidence concerns the gene SOAT1 and neoplasm.